HEADER HYDROLASE 09-APR-02 1LEE TITLE CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH TITLE 2 INHIBITOR RS367 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 123-453; COMPND 5 SYNONYM: ASPARTIC HEMOGLOBINASE II, PFAPD; COMPND 6 EC: 3.4.23.39 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833 KEYWDS PLASMEPSIN, ASPARTIC PROTEASE, PLASMODIUM FALCIPARUM, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR O.A.ASOJO,E.AFONINA,S.V.GULNIK,B.YU,J.W.ERICKSON,R.RANDAD,D.MEHADJED, AUTHOR 2 A.M.SILVA REVDAT 7 16-AUG-23 1LEE 1 REMARK REVDAT 6 27-OCT-21 1LEE 1 REMARK SEQADV REVDAT 5 13-JUL-11 1LEE 1 VERSN REVDAT 4 24-FEB-09 1LEE 1 VERSN REVDAT 3 09-NOV-04 1LEE 1 JRNL REMARK MASTER REVDAT 2 04-DEC-02 1LEE 1 JRNL REVDAT 1 09-OCT-02 1LEE 0 JRNL AUTH O.A.ASOJO,E.AFONINA,S.V.GULNIK,B.YU,J.W.ERICKSON,R.RANDAD, JRNL AUTH 2 D.MEDJAHED,A.M.SILVA JRNL TITL STRUCTURES OF SER205 MUTANT PLASMEPSIN II FROM PLASMODIUM JRNL TITL 2 FALCIPARUM AT 1.8 A IN COMPLEX WITH THE INHIBITORS RS367 AND JRNL TITL 3 RS370. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 58 2001 2002 JRNL REFN ISSN 0907-4449 JRNL PMID 12454457 JRNL DOI 10.1107/S0907444902014695 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH O.A.ASOJO,S.V.GULNIK,E.AFONINA,B.YU,J.A.ELLMAN,T.S.HAQUE, REMARK 1 AUTH 2 A.M.SILVA REMARK 1 TITL NOVEL UNCOMPLEXED AND COMPLEXED STRUCTURES OF PLASMEPSIN II, REMARK 1 TITL 2 AN ASPARTIC PROTEASE FROM PLASMODIUM FALCIPARUM. REMARK 1 REF J.MOL.BIOL. V. 327 173 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12614616 REMARK 1 DOI 10.1016/S0022-2836(03)00036-6 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 600592.250 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 70.4 REMARK 3 NUMBER OF REFLECTIONS : 22291 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1113 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 40.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2007 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE : 0.3480 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 107 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.034 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2617 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 338 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.94000 REMARK 3 B22 (A**2) : 4.65000 REMARK 3 B33 (A**2) : -3.71000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.020 REMARK 3 BOND ANGLES (DEGREES) : 2.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.500 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.710 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 29.480; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 8.570 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.48 REMARK 3 BSOL : 300.0 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LEE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAY-02. REMARK 100 THE DEPOSITION ID IS D_1000015875. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-98 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9200 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23619 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 71.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 33.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.19000 REMARK 200 R SYM FOR SHELL (I) : 0.22000 REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1SME REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.94500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.41500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 61.54000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.94500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.41500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 61.54000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.94500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 42.41500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 61.54000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.94500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 42.41500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 61.54000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 75.89000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 75.89000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 84.83000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 75.89000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 84.83000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 1 -100.30 62.82 REMARK 500 SER A 2 -135.71 78.60 REMARK 500 ASN A 3 138.78 74.48 REMARK 500 ASP A 69 -71.53 -128.47 REMARK 500 PRO A 138 150.13 -49.63 REMARK 500 HIS A 161 133.98 -38.41 REMARK 500 ASP A 162 -21.52 69.02 REMARK 500 LYS A 163 -73.11 -91.02 REMARK 500 LEU A 191 -89.28 -137.21 REMARK 500 ASN A 233 -10.88 67.97 REMARK 500 PHE A 241 -47.45 73.19 REMARK 500 PRO A 243 7.22 -66.02 REMARK 500 HIS A 276 -102.18 94.50 REMARK 500 ILE A 277 101.19 68.30 REMARK 500 GLU A 278 56.89 77.42 REMARK 500 ASP A 279 -127.42 -94.39 REMARK 500 PRO A 282 -105.16 -82.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R36 A 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX REMARK 900 WITH INHIBITOR RS370 REMARK 900 RELATED ID: 1LF3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX REMARK 900 WITH INHIBITOR EH58 REMARK 900 RELATED ID: 1LF4 RELATED DB: PDB REMARK 900 STRUCTURE OF PLASMEPSIN II DBREF 1LEE A -1 329 UNP P46925 PLM2_PLAFA 123 453 SEQADV 1LEE SER A 205 UNP P46925 MET 329 ENGINEERED MUTATION SEQRES 1 A 331 LEU GLY SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE SEQRES 2 A 331 GLN ASN ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP SEQRES 3 A 331 ASN GLN GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER SEQRES 4 A 331 ALA ASN LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA SEQRES 5 A 331 GLY CYS LEU THR LYS HIS LEU TYR ASP SER SER LYS SER SEQRES 6 A 331 ARG THR TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN SEQRES 7 A 331 TYR VAL SER GLY THR VAL SER GLY PHE PHE SER LYS ASP SEQRES 8 A 331 LEU VAL THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE SEQRES 9 A 331 ILE GLU VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR SEQRES 10 A 331 THR ALA SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP SEQRES 11 A 331 LYS ASP LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL SEQRES 12 A 331 GLU LEU LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE SEQRES 13 A 331 THR PHE TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE SEQRES 14 A 331 LEU THR ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY SEQRES 15 A 331 PRO LEU THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP SEQRES 16 A 331 GLN ILE THR LEU ASP ALA HIS VAL GLY ASN ILE SER LEU SEQRES 17 A 331 GLU LYS ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA SEQRES 18 A 331 ILE THR VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN SEQRES 19 A 331 ASN LEU ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR SEQRES 20 A 331 VAL THR LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU SEQRES 21 A 331 PHE THR SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU SEQRES 22 A 331 TYR TYR LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU SEQRES 23 A 331 CYS MET LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO SEQRES 24 A 331 THR PHE ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE SEQRES 25 A 331 THR VAL PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA SEQRES 26 A 331 LEU ALA LYS LYS ASN LEU HET R36 A 500 39 HETNAM R36 4-AMINO-N-{4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3- HETNAM 2 R36 HYDROXY-1-ISOBUTYL-5-PHENYL-PENTYL}-BENZAMIDE FORMUL 2 R36 C32 H41 N3 O4 FORMUL 3 HOH *338(H2 O) HELIX 1 1 ALA A 50 LYS A 55 5 6 HELIX 2 2 ASP A 59 SER A 63 5 5 HELIX 3 3 THR A 108 GLU A 112 5 5 HELIX 4 4 THR A 114 SER A 118 5 5 HELIX 5 5 TRP A 128 SER A 132 5 5 HELIX 6 6 PRO A 138 GLN A 146 1 9 HELIX 7 7 GLU A 174 ARG A 176 5 3 HELIX 8 8 PRO A 223 GLN A 232 1 10 HELIX 9 9 GLU A 269 TYR A 273 1 5 HELIX 10 10 GLY A 302 LYS A 308 1 7 SHEET 1 A15 TYR A 178 LYS A 186 0 SHEET 2 A15 SER A 319 ALA A 325 -1 N VAL A 320 O GLU A 185 SHEET 3 A15 TYR A 309 ASP A 314 -1 N PHE A 310 O ALA A 323 SHEET 4 A15 LEU A 153 TYR A 157 -1 O PHE A 154 N PHE A 313 SHEET 5 A15 GLY A 166 ILE A 170 -1 O PHE A 167 N TYR A 157 SHEET 6 A15 ASP A 4 PHE A 11 -1 O ASP A 4 N ILE A 170 SHEET 7 A15 MET A 15 VAL A 22 -1 O MET A 15 N PHE A 11 SHEET 8 A15 GLN A 27 ASP A 34 -1 N GLN A 27 O VAL A 22 SHEET 9 A15 GLY A 122 GLY A 125 1 N GLY A 122 O THR A 30 SHEET 10 A15 LEU A 40 PRO A 43 -1 N TRP A 41 O ILE A 123 SHEET 11 A15 LEU A 96 ASP A 107 1 N ILE A 103 O LEU A 40 SHEET 12 A15 GLY A 80 VAL A 93 -1 N SER A 83 O ASP A 107 SHEET 13 A15 GLU A 67 TYR A 77 -1 N GLU A 67 O LYS A 88 SHEET 14 A15 GLY A 80 VAL A 93 -1 O GLY A 80 N TYR A 77 SHEET 15 A15 MET A 15 VAL A 22 -1 O GLU A 21 N THR A 92 SHEET 1 B 7 LYS A 265 LEU A 268 0 SHEET 2 B 7 PHE A 257 THR A 260 -1 N PHE A 257 O LEU A 268 SHEET 3 B 7 GLN A 194 VAL A 201 -1 N ASP A 198 O THR A 260 SHEET 4 B 7 ILE A 204 VAL A 213 -1 O ILE A 204 N VAL A 201 SHEET 5 B 7 THR A 298 LEU A 301 1 O PHE A 299 N ILE A 212 SHEET 6 B 7 ILE A 220 VAL A 222 -1 N THR A 221 O ILE A 300 SHEET 7 B 7 ILE A 289 GLY A 291 1 O ILE A 290 N VAL A 222 SHEET 1 C 4 ILE A 237 LYS A 238 0 SHEET 2 C 4 TYR A 245 LEU A 248 -1 N VAL A 246 O ILE A 237 SHEET 3 C 4 LEU A 284 LEU A 287 -1 N CYS A 285 O THR A 247 SHEET 4 C 4 LEU A 274 HIS A 276 -1 N GLN A 275 O MET A 286 SSBOND 1 CYS A 47 CYS A 52 1555 1555 1.98 SSBOND 2 CYS A 249 CYS A 285 1555 1555 2.04 CISPEP 1 GLU A 112 PRO A 113 0 0.10 SITE 1 AC1 18 ASP A 34 GLY A 36 ASN A 76 TYR A 77 SITE 2 AC1 18 VAL A 78 SER A 79 PHE A 111 ILE A 123 SITE 3 AC1 18 LEU A 131 TYR A 192 ASP A 214 GLY A 216 SITE 4 AC1 18 THR A 217 SER A 218 PRO A 240 PHE A 241 SITE 5 AC1 18 PRO A 295 HOH A1003 CRYST1 75.890 84.830 123.080 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013180 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011790 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008120 0.00000